Corrigendum.
Corrigendum to "Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance" [J. Cardiol. 56 (2010) 111–117] The authors of the manuscript would like to correct affiliation of Mr. Nobuo Shirahashi, who was mentioned in the Appendix section of this article. The correct affiliation of Mr. Shirahashi was Novartis Pharma KK and Department of Preventive Medicine and Environmental Health, Osaka City University Medical School, Osaka, Japan.